SchisandraIntroductionSchisandra is a vine that grows in Asia and parts of Europe. The berries have been used to improve liver function and overall well-being. It can be taken as a pill, powder, or extract. Schisandra can also be made into tea or juice. DosagesThere are no advised doses for schisandra. What Research ShowsEditorial process and description of evidence categories can be found at EBSCO NAT Editorial Process. Safety NotesIt is likely safe for most adults to take schisandra in small doses for a short time. Not enough studies have been done to say whether it is safe to use for a long period. It is not known whether it is safe to take by women who are breastfeeding. Schisandra may be unsafe during pregnancy. Interactions Talk to your doctor about any supplements or therapy you would like to use. Some can interfere with treatment or make conditions worse, such as:
References►A. Menopause A1. Park JY, Kim KH. A randomized, double-blind, placebo-controlled trial of Schisandra chinensis for menopausal symptoms. Climacteric. 2016 Dec;19(6):574-580. Epub 2016 Oct 20. B. Safety B1. Xin HW, Li Q, et al. Effects of Schisandra sphenanthera extract on the blood concentration of tacrolimus in renal transplant recipients. Eur J Clin Pharmacol. 2011 Dec;67(12):1309-1311. B2. Gurley BJ, Fifer EK, et al. Pharmacokinetic herb-drug interactions (part 2): drug interactions involving popular botanical dietary supplements and their clinical relevance. Planta Med. 2012 Sep;78(13):1490-1514. Last reviewed July 2019 by EBSCO NAT Review Board
Eric Hurwitz, DC Last Updated: 3/30/2020 | |
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation. This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition. To send comments or feedback to our Editorial Team regarding the content please email us at healthlibrarysupport@ebsco.com. Our Health Library Support team will respond to your email request within 2 business days. | |